Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maribavir prophylaxis for CMV in stem cell transplant recipients
NCT00411645Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2006
- Primary completion
- Nov 2008
- Modality
- Orthosteric Ligands
- Countries
- 9
01
Overview
A Phase 3 trial of maribavir in cytomegalovirus disease (CMV), sponsored by Takeda. Started Dec 2006; status: completed.
02
Drugs
maribavir
03
Conditions
cytomegalovirus disease (CMV)
Beyond the preview
Go deeper on NCT00411645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00411645.